StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$96.43+2.52 (+2.68%)

Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%

TransMedics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

TransMedics's operating cash flow for the twelve months ending Jun 30, 2026 was $145.93M, up 26.6% year over year. For fiscal 2025 it was $192.84M, up 295.1% from the year before. The highest annual figure on record is $192.84M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$192.84M+295.1%
FY2024Dec 31, 2024$48.80M–
FY2023Dec 31, 2023-$13.03M–
FY2022Dec 31, 2022-$45.82M–
FY2021Dec 31, 2021-$28.86M–
FY2020Dec 31, 2020-$30.27M–
FY2019Dec 28, 2019-$32.29M–
FY2018Dec 29, 2018-$25.98M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.31M-81.1%
Q1 FY2026Mar 31, 2026$24.53M–
Q4 FY2025Dec 31, 2025$34.51M+75.5%
Q3 FY2025Sep 30, 2025$69.57M+914.6%
Q2 FY2025Jun 30, 2025$91.61M+256.2%
Q1 FY2025Mar 31, 2025-$2.86M–
Q4 FY2024Dec 31, 2024$19.66M+136.8%
Q3 FY2024Sep 30, 2024$6.86M–
Q2 FY2024Jun 30, 2024$25.72M–
Q1 FY2024Mar 31, 2024-$3.44M–
Q4 FY2023Dec 31, 2023$8.30M–
Q3 FY2023Sep 30, 2023-$6.87M–
Q2 FY2023Jun 30, 2023-$5.80M–
Q1 FY2023Mar 31, 2023-$8.66M–
Q4 FY2022Dec 31, 2022-$4.04M–
Q3 FY2022Sep 30, 2022-$14.28M–
Q2 FY2022Jun 30, 2022-$9.09M–
Q1 FY2022Mar 31, 2022-$18.41M–
Q4 FY2021Dec 31, 2021-$6.65M–
Q3 FY2021Sep 30, 2021-$9.35M–
Q2 FY2021Jun 30, 2021-$5.54M–
Q1 FY2021Mar 31, 2021-$7.33M–
Q4 FY2020Dec 31, 2020-$7.14M–
Q3 FY2020Sep 30, 2020-$6.41M–
Q2 FY2020Jun 30, 2020-$8.54M–
Q1 FY2020Mar 31, 2020-$8.18M–
Q4 FY2019Dec 28, 2019-$7.26M–
Q3 FY2019Sep 28, 2019-$5.60M–
Q2 FY2019Jun 29, 2019-$12.16M–
Q1 FY2019Mar 30, 2019-$7.27M–
Q4 FY2018Dec 29, 2018-$6.12M–
Q3 FY2018Sep 29, 2018-$6.06M–
Q2 FY2018Jun 30, 2018-$7.47M–
Q1 FY2018Mar 31, 2018-$6.33M–

More TransMedics figures

See a number that looks wrong?